Skip to content

Clinical trials

Leukemia, Myeloid, Chronic-Phase trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20071
20081
20091
20111
20123
20131
20151
20181
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center6
Bristol-Myers Squibb3
Il-Yang Pharm. Co., Ltd.2
Ascentage Pharma Group Inc.1
Enliven Therapeutics1
Korean Society of Hematology1
Takeda1
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
The Korean Society of Blood and Marrow Transplantation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive7
Leukemia, Myeloid, Accelerated Phase7
Leukemia6
Blast Crisis5
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5
Myelodysplastic Syndromes5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Congenital Abnormalities4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.